İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

AYDIN AKTAŞ

PROFESÖR

İNÖNÜ ÜNİVERSİTESİ SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU TIBBİ HİZMETLER VE TEKNİKLER BÖLÜMÜ

  • Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  • Yan Dal Kimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 136
  • Proje 0
  • Kitap 0
  • Bildiri 56
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 13 Q2 83 Q3 30 Q4 3
WoS (JCR) Q1 17 Q2 56 Q3 47 Q4 8
TR Index 3 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 2
Üst %10 makale 39
Ort. yüzdelik 76.0%
Üst %1 payı 1.6%
Üst %10 payı 30.5%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 136 yayın

Scopus (SJR)
Q1 13 Q2 83 Q3 30 Q4 3
WoS (JCR)
Q1 17 Q2 56 Q3 47 Q4 8
TR Index
3 makale

Makale listesi

  1. 2026 4‐Methylsulfonylbenzyl Substituted N‐Heterocyclic Carbene‐Ruthenium (II) Complexes: Design, Synthesis, Characterization, and Anticancer Activities ChemistrySelect DOI 10.1002/slct.202505574 YÖKSİS SJR Q3 JCR Q3 OpenAlex 84.6%
  2. 2026 New morpholine or triphenylphosphine-liganded palladium(II) N-heterocyclic carbene complexes: Synthesis, characterization, crystal structure, and anticancer activity Inorganica Chimica Acta DOI 10.1016/j.ica.2026.123062 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 92.8%
  3. 2026 Activities of New Dinuclear PEPPSI‐Precatalysts Bearing Bis‐benzimidazole Ligands in the Suzuki–Miyaura Coupling Reaction ChemistrySelect DOI 10.1002/slct.73286 YÖKSİS SJR Q3 JCR Q3 OpenAlex 28.4%
  4. 2026 Phenylsulfonylethyl‐Substituted Benzimidazolium Salts: Synthesis, Characterization, Crystal Structure, Molecular Docking, and Inhibitory Properties Against Various Enzymes Journal of Biochemical and Molecular Toxicology DOI 10.1002/jbt.70893 YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.4%
  5. 2026 New silver N-heterocyclic carbene (NHC) complexes containing fluoro and acetyl groups: design, characterization, molecular docking studies, and inhibition properties against several metabolic enzymes Polyhedron DOI 10.1016/j.poly.2025.117931 YÖKSİS SJR Q3 JCR Q2 OpenAlex 79.5%
  6. 2026 Novel ruthenium(II)oxothiazolidine complexes: Design, synthesis, characterization, DNA binding and anticancer activity Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.144493 YÖKSİS SJR Q2 JCR Q2 OpenAlex 29.7%
  7. 2025 5(6)‐Benzoyl‐Substituted Benzimidazoles and Their Benzimidazolium Salts: Design, Synthesis, Characterization, Crystal Structure, and Some Metabolic Enzymes Inhibition Properties Archiv der Pharmazie DOI 10.1002/ardp.70063 YÖKSİS SJR Q2 JCR Q2 OpenAlex 59.6%
  8. 2025 Corrosion inhibition of mild steel in acidic media using benzimidazolium salts: An experimental and computational approach Colloids and Surfaces A: Physicochemical and Engineering Aspects DOI 10.1016/j.colsurfa.2025.137815 YÖKSİS SJR Q1 JCR Q2 OpenAlex 84.7%
  9. 2025 4-Phenylthiazol-1,2,3-triazole derivatives as new potential α-glucosidase and α-amylase inhibitors Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.141919 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 92.9%
  10. 2025 Imidazol-2-ylidene-Pd-PEPPSI complexes containing 4-acetylphenyl side arm: Synthesis, characterization, crystal structure, and applications in Suzuki, Heck and Sonogashira reactions Inorganica Chimica Acta DOI 10.1016/j.ica.2025.122845 YÖKSİS SJR Q2 JCR Q2 OpenAlex 74.0%
  11. 2025 Rhodanine-pyridinium derivatives as a new category of cholinesterase inhibitors: Design, synthesis, in vitro and in silico enzymatic evaluations International Journal of Biological Macromolecules DOI 10.1016/j.ijbiomac.2025.145731 YÖKSİS SJR Q1 JCR Q1 OpenAlex 81.8%
  12. 2025 Design, Synthesis, Characterization, and Antitumor Activities of Benzimidazole-functionalized Organoruthenium Complexes Bearing Fluorine Group Medicinal Chemistry DOI 10.2174/0115734064331622241113032042 YÖKSİS SJR Q3 JCR Q3 OpenAlex 59.3%
  13. 2025 Imidazol‐2‐Ylidene‐Silver(I) Complexes Bearing 4‐Acetylphenyl Side Arm: Design, Synthesis, Characterization, Crystal Structure, and Inhibitory Properties Against Some Metabolic Enzymes Applied Organometallic Chemistry DOI 10.1002/aoc.70258 YÖKSİS SJR Q2 JCR Q1 OpenAlex 79.9%
  14. 2025 New benzimidazole–indole–amide derivatives as potent α‐glucosidase and acetylcholinesterase inhibitors Archiv der Pharmazie DOI 10.1002/ardp.202400354 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 95.0%
  15. 2025 Benzimidazolium salts bearing ester group: Synthesis, characterization, crystal structure, molecular docking studies, and inhibitory properties against metabolic enzymes Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.140342 YÖKSİS SJR Q2 JCR Q2 OpenAlex 78.9%
  16. 2024 Design, Synthesis of 3‐(Aryl)‐1‐(2‐p‐tolylthiazol‐4‐yl)prop‐2‐en‐1‐ones as Alpha(α)‐Amylase Inhibitors Chemistry & Biodiversity DOI 10.1002/cbdv.202401021 YÖKSİS SJR Q3 JCR Q3 OpenAlex 4.7%
  17. 2024 Bisbenzimidazole salts and their in silico–in vitro inhibitory abilities on hCA I, hCA II, and AChE enzymes Monatshefte für Chemie - Chemical Monthly DOI 10.1007/s00706-024-03204-5 YÖKSİS SJR Q3 JCR Q3 OpenAlex 59.5%
  18. 2024 Design of novel benzimidazole-propane hydrazide derivatives as α-glucosidase and α-amylase inhibitors: in vitro and in silico studies Medicinal Chemistry Research DOI 10.1007/s00044-024-03328-7 YÖKSİS SJR Q2 JCR Q3 OpenAlex 77.2%
  19. 2024 New palladium complexes with N‐heterocyclic carbene and morpholine ligands: Synthesis, characterization, crystal structure, molecular docking, and biological activities Journal of Biochemical and Molecular Toxicology DOI 10.1002/jbt.23554 YÖKSİS SJR Q2 JCR Q2 OpenAlex 84.8%
  20. 2024 Synthesis, characterization, crystal structure, biological activities, and molecular docking study of the (NHC)Pd(II)(Morp) (NHC: N-heterocyclic carbene, Morp: Morpholine) complexes Polyhedron DOI 10.1016/j.poly.2024.117016 YÖKSİS SJR Q3 JCR Q2 OpenAlex 89.2%

Akademisyenlere dön